Fig 1.
Primary, secondary, and exploratory outcomes of the study.
Fig 2.
Eligibility criteria for participants.
Abbreviations: ADT, androgen deprivation therapy; DM, diabetes mellitus; HbA1c, glycated hemoglobin; MR spectroscopy, magnetic resonance spectroscopy. *Within 3 months from enrollment. ** Participants who have contraindications to MRS but are otherwise eligible will be enrolled.
Table 1.
Schedule of enrollment and assessments.
Fig 3.
Anticipated patterns of changes in plasma glucose concentrations according to the primary site of insulin resistance.
* *Based on information from Reference #33.